Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA

93Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Antisense oligonucleotides and small interfering RNA have enormous potential for the treatment of a number of diseases, including cancer. However, several impediments to their widespread use as drugs still have to be overcome: In particular their lack of stability in physiological fluids and their poor penetration Into cells. Association with or encapsulation within nano- and microsized drug delivery systems could help to solve these problems. In this review, we describe the progress that has been made using delivery systems composed of natural or synthetic polymers in the form of complexes, nanoparticles or microparticles. © 2009 The British Pharmacological Society All rights reserved.

Cite

CITATION STYLE

APA

Fattal, E., & Barratt, G. (2009, May). Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00148.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free